{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:01:05Z","timestamp":1767175265980,"version":"build-2238731810"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"Singapore National Medical Research Council","doi-asserted-by":"crossref","award":["NMRC\/CSA-SI\/0005\/2015"],"award-info":[{"award-number":["NMRC\/CSA-SI\/0005\/2015"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cardiovascular disease remains the leading cause of death in Singapore. Uncontrolled hypertension confers the highest attributable risk of CVD and remains a significant public health issue with sub-optimal blood pressure (BP) control rates. The aim of the trial is to evaluate the effectiveness and cost-effectiveness of a multicomponent intervention (MCI) versus usual care on lowering BP among adults with uncontrolled hypertension visiting primary care clinics in Singapore. This article describes the statistical analysis plan for the primary and secondary objectives related to intervention effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study is a cluster randomized trial enrolling 1000 participants with uncontrolled hypertension aged \u2265\u200940\u2009years from eight primary care clinics in Singapore. The unit of randomization is the clinic, with eight clusters (clinics) randomized in a 1:1 ratio to either MCI or usual care. All participants will be assessed at baseline, 12\u2009months, and 24\u2009months with measurements of systolic and diastolic BP, antihypertensive and statin medication use, medication adherence, physical activity level, anthropometric parameters, smoking status, and dietary habits.<\/jats:p>\n                    <jats:p>The primary objective of this study is to assess the effectiveness of MCI versus usual care on mean SBP at the 2-year follow-up. The primary outcome is SBP at 24\u2009months.<\/jats:p>\n                    <jats:p>SBP at baseline, 12, and 24\u2009months will be modeled at the subject level using a likelihood-based, linear mixed-effects model repeated measures (MMRM) analysis with treatment group and follow-up as fixed effects, random cluster (clinic) effects, Gaussian error distribution, and adjustment to degrees of freedom using the Satterthwaite approximation. Secondary outcomes will be analyzed using a similar modeling approach incorporating generalized techniques appropriate for the type of outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The trial will allow us to determine whether the MCI has an impact on BP and cardiovascular risk factors over a 2-year follow-up period and inform recommendations for health planners in scaling up these strategies for the benefit of society at large. A pre-specified and pre-published statistical analysis plan mitigates reporting bias and data driven approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\/show\/NCT02972619\">NCT02972619<\/jats:ext-link>\n                      . Registered on 23 November 2016.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-020-05016-4","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T04:02:51Z","timestamp":1611028971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Statistical analysis plan for management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: the SingHypertension pragmatic cluster randomized controlled trial"],"prefix":"10.1186","volume":"22","author":[{"name":"for SingHypertension Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"John C.","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Halaand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupesh M.","family":"Shirore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7454-8376","authenticated-orcid":false,"given":"Tazeen H.","family":"Jafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"issue":"1","key":"5016_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1053\/j.ajkd.2020.01.022","volume":"76","author":"E O'Lone","year":"2020","unstructured":"O'Lone E, Viecelli AK, Craig JC, Tong A, Sautenet B, Herrington WG, et al. Establishing core cardiovascular outcome measures for trials in hemodialysis: report of an international consensus workshop. Am J Kidney Dis. 2020;76(1):109\u201320.","journal-title":"Am J Kidney Dis"},{"key":"5016_CR2","unstructured":"Evaluation TIfHMa. Seattle, WA: University of Washington; 2019 [Available from: http:\/\/www.healthdata.org\/singapore. Accessed 13 Feb 2020."},{"key":"5016_CR3","unstructured":"division: Eadc. National Health Survey: Singapore: Ministry of Health; 2010 [Available from: https:\/\/www.moh.gov.sg\/content\/moh_web\/home\/Publications\/Reports\/2011\/national_health_survey2010. Accessed 13 Feb 2020."},{"issue":"10022","key":"5016_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957\u201367.","journal-title":"Lancet."},{"issue":"1","key":"5016_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13063-018-2559-x","volume":"19","author":"TH Jafar","year":"2018","unstructured":"Jafar TH, Tan NC, Allen JC, Finkelstein EA, Goh P, Moey P, et al. Management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: the SingHypertension cluster randomized trial. Trials. 2018;19(1):180.","journal-title":"Trials."},{"key":"5016_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13104-015-1042-y","volume":"8","author":"J Singh","year":"2015","unstructured":"Singh J, Liddy C, Hogg W, Taljaard M. Intracluster correlation coefficients for sample size calculations related to cardiovascular disease prevention and management in primary care practices. BMC Res Notes. 2015;8:89.","journal-title":"BMC Res Notes"},{"issue":"9","key":"5016_CR7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.7326\/0003-4819-151-9-200911030-00004","volume":"151","author":"TH Jafar","year":"2009","unstructured":"Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, et al. Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial. Ann Intern Med. 2009;151(9):593\u2013601.","journal-title":"Ann Intern Med"},{"issue":"8","key":"5016_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1911965","volume":"382","author":"TH Jafar","year":"2020","unstructured":"Jafar TH, Gandhi M, de Silva HA, Jehan I, Naheed A, Finkelstein EA, et al. A community-based intervention for managing hypertension in rural South Asia. N Engl J Med. 2020;382(8):717\u201326.","journal-title":"N Engl J Med"},{"issue":"1","key":"5016_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12913-016-1703-0","volume":"16","author":"R Kuhmmer","year":"2016","unstructured":"Kuhmmer R, Lazzaretti RK, Guterres CM, Raimundo FV, Leite LE, Delabary TS, et al. Effectiveness of multidisciplinary intervention on blood pressure control in primary health care: a randomized clinical trial. BMC Health Serv Res. 2016;16(1):456.","journal-title":"BMC Health Serv Res"},{"key":"5016_CR10","doi-asserted-by":"publisher","first-page":"i708","DOI":"10.1136\/bmj.i708","volume":"352","author":"J Mant","year":"2016","unstructured":"Mant J, McManus RJ, Roalfe A, Fletcher K, Taylor CJ, Martin U, et al. Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke--Blood Pressure) randomised controlled trial. Bmj. 2016;352:i708.","journal-title":"Bmj."},{"issue":"12","key":"5016_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013096","volume":"6","author":"CJ Coffman","year":"2016","unstructured":"Coffman CJ, Edelman D, Woolson RF. To condition or not condition? Analysing \u2018change\u2019 in longitudinal randomised controlled trials. BMJ Open. 2016;6(12):e013096.","journal-title":"BMJ Open"},{"key":"5016_CR12","doi-asserted-by":"publisher","first-page":"k1121","DOI":"10.1136\/bmj.k1121","volume":"360","author":"R Hooper","year":"2018","unstructured":"Hooper R, Forbes A, Hemming K, Takeda A, Beresford L. Analysis of cluster randomised trials with an assessment of outcome at baseline. BMJ. 2018;360:k1121.","journal-title":"BMJ."},{"issue":"16","key":"5016_CR13","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","volume":"120","author":"G Mazzaglia","year":"2009","unstructured":"Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598\u2013605.","journal-title":"Circulation."},{"issue":"2","key":"5016_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/jama.297.2.177","volume":"297","author":"JN Rasmussen","year":"2007","unstructured":"Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. Jama. 2007;297(2):177\u201386.","journal-title":"Jama."},{"issue":"6","key":"5016_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D'Agostino Sr","year":"2008","unstructured":"D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743\u201353.","journal-title":"Circulation."},{"key":"5016_CR16","unstructured":"IPAQ Research Committee. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms. 2005. http:\/\/www.ipaq.ki.se\/scoring.pdf."},{"issue":"4","key":"5016_CR17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1053\/j.ajkd.2010.02.337","volume":"55","author":"AS Levey","year":"2010","unstructured":"Levey AS, Stevens LA. Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis. 2010;55(4):622\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"5016_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/eurheartj\/ehq448","volume":"32","author":"C McGorrian","year":"2010","unstructured":"McGorrian C, Yusuf S, Islam S, Jung H, Rangarajan S, Avezum A, et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. Eur Heart J. 2010;32(5):581\u20139.","journal-title":"Eur Heart J"},{"issue":"13","key":"5016_CR19","doi-asserted-by":"publisher","first-page":"e793","DOI":"10.1161\/CIR.0000000000000467","volume":"135","author":"DM Lloyd-Jones","year":"2017","unstructured":"Lloyd-Jones DM, Huffman MD, Karmali KN, Sanghavi DM, Wright JS, Pelser C, et al. Estimating longitudinal risks and benefits from cardiovascular preventive therapies among Medicare patients: the million hearts longitudinal ASCVD risk assessment tool: a special report from the American Heart Association and American College of Cardiology. Circulation. 2017;135(13):e793\u2013813.","journal-title":"Circulation."},{"key":"5016_CR20","volume-title":"Global Adult Tobacco Survey (GATS): core questionnaire with optional questions, version 2.1","author":"Group GATSC","year":"2014","unstructured":"Group GATSC. Global Adult Tobacco Survey (GATS): core questionnaire with optional questions, version 2.1. Atlanta, GA: Centers for Disease Control and Prevention; 2014."},{"issue":"1","key":"5016_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hec.3564","volume":"27","author":"NJ Devlin","year":"2018","unstructured":"Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018;27(1):7\u201322.","journal-title":"Health Econ"},{"key":"5016_CR22","unstructured":"WHO Expert Consultation. Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation. Geneva: 2008;2011."},{"issue":"1","key":"5016_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1440-1681.1993.tb01496.x","volume":"20","author":"T Kawasaki","year":"1993","unstructured":"Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol. 1993;20(1):7\u201314.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"5016_CR24","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/ije\/dyy057","volume":"47","author":"C Leyrat","year":"2018","unstructured":"Leyrat C, Morgan KE, Leurent B, Kahan BC. Cluster randomized trials with a small number of clusters: which analyses should be used? Int J Epidemiol. 2018;47(3):1012.","journal-title":"Int J Epidemiol"},{"key":"5016_CR25","unstructured":"Kincaid C. Guidelines for selecting the covariance structure in mixed model analysis, COMSYS Information Technology Services, Inc., Portage, MI. [Available from: https:\/\/support.sas.com\/resources\/papers\/proceedings\/proceedings\/sugi30\/198-30.pdf. Accessed 13 Feb 2020."},{"issue":"1","key":"5016_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12874-019-0750-8","volume":"19","author":"JE Bolzern","year":"2019","unstructured":"Bolzern JE, Mitchell A, Torgerson DJ. Baseline testing in cluster randomised controlled trials: should this be done? BMC Med Res Methodol. 2019;19(1):106.","journal-title":"BMC Med Res Methodol"},{"key":"5016_CR27","volume-title":"Waist circumference and waist-hip ratio. Report of a WHO Expert Consultation","author":"WE Consultation","year":"2008","unstructured":"Consultation WE. Waist circumference and waist-hip ratio. Report of a WHO Expert Consultation. Geneva: World Health Organization; 2008."},{"key":"5016_CR28","doi-asserted-by":"crossref","unstructured":"Buse JB, Bain SC, Mann JFE, Nauck MA, Nissen SE, Pocock S, et al. Cardiovascular risk reduction with liraglutide: an exploratory mediation analysis of the LEADER trial. Diabetes Care. 2020;43:dc192251.","DOI":"10.2337\/figshare.12106860"},{"issue":"2","key":"5016_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2337\/dc17-1096","volume":"41","author":"SE Inzucchi","year":"2018","unstructured":"Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, et al. How does empagliflozin reduce cardiovascular mortality? Insights from a mediation analysis of the EMPA-REG OUTCOME trial. Diabetes Care. 2018;41(2):356\u201363.","journal-title":"Diabetes Care"},{"key":"5016_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jclinepi.2019.10.001","volume":"117","author":"TT Vo","year":"2020","unstructured":"Vo TT, Superchi C, Boutron I, Vansteelandt S. The conduct and reporting of mediation analysis in recently published randomized controlled trials: results from a methodological systematic review. J Clin Epidemiol. 2020;117:78\u201388.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"5016_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/pst.1549","volume":"12","author":"B Ratitch","year":"2013","unstructured":"Ratitch B, O'Kelly M, Tosiello R. Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models. Pharm Stat. 2013;12(6):337\u201347.","journal-title":"Pharm Stat"},{"issue":"1","key":"5016_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12913-016-1491-6","volume":"16","author":"TH Jafar","year":"2016","unstructured":"Jafar TH, Tan NC, Allen JC, Pradhan SS, Goh P, Tavajoh S, et al. Management of hypertension and multiple risk factors to enhance cardiovascular health - a feasibility study in Singapore polyclinics. BMC Health Serv Res. 2016;16(1):229.","journal-title":"BMC Health Serv Res"}],"updated-by":[{"DOI":"10.1186\/s13063-021-05097-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-05016-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-020-05016-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-05016-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T18:02:14Z","timestamp":1612807334000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-05016-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5016"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-05016-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"26 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13063-021-05097-9","URL":"https:\/\/doi.org\/10.1186\/s13063-021-05097-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for the study has been obtained from the Ethics Review Committee at the Duke-NUS Graduate Medical School, Singapore, and SingHealth Ethics Review Committee. Written informed consent will be obtained from the participants before participation in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}